nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—Toremifene—breast cancer	0.25	0.614	CrCtD
Dextropropoxyphene—Tamoxifen—breast cancer	0.157	0.386	CrCtD
Dextropropoxyphene—CYP2D6—breast cancer	0.0544	0.538	CbGaD
Dextropropoxyphene—CYP3A4—breast cancer	0.0467	0.462	CbGaD
Dextropropoxyphene—Tamoxifen—Toremifene—breast cancer	0.0175	0.0764	CrCrCtD
Dextropropoxyphene—Loperamide—Toremifene—breast cancer	0.0169	0.074	CrCrCtD
Dextropropoxyphene—Toremifene—Tamoxifen—breast cancer	0.016	0.0699	CrCrCtD
Dextropropoxyphene—Doxylamine—Toremifene—breast cancer	0.0146	0.0639	CrCrCtD
Dextropropoxyphene—Phenoxybenzamine—Toremifene—breast cancer	0.0139	0.0607	CrCrCtD
Dextropropoxyphene—Methadyl Acetate—Tamoxifen—breast cancer	0.0106	0.0465	CrCrCtD
Dextropropoxyphene—Levomethadyl Acetate—Tamoxifen—breast cancer	0.0106	0.0465	CrCrCtD
Dextropropoxyphene—Loperamide—Tamoxifen—breast cancer	0.0106	0.0465	CrCrCtD
Dextropropoxyphene—CYP2C9—Anastrozole—breast cancer	0.0103	0.0572	CbGbCtD
Dextropropoxyphene—Clofedanol—Toremifene—breast cancer	0.01	0.0439	CrCrCtD
Dextropropoxyphene—CYP2C8—Lapatinib—breast cancer	0.00986	0.0547	CbGbCtD
Dextropropoxyphene—Benzphetamine—Toremifene—breast cancer	0.0097	0.0425	CrCrCtD
Dextropropoxyphene—Orphenadrine—Toremifene—breast cancer	0.0097	0.0425	CrCrCtD
Dextropropoxyphene—Doxylamine—Tamoxifen—breast cancer	0.00917	0.0402	CrCrCtD
Dextropropoxyphene—Benzyl Benzoate—Toremifene—breast cancer	0.00899	0.0394	CrCrCtD
Dextropropoxyphene—Phenoxybenzamine—Tamoxifen—breast cancer	0.00871	0.0381	CrCrCtD
Dextropropoxyphene—Diphenhydramine—Toremifene—breast cancer	0.00861	0.0377	CrCrCtD
Dextropropoxyphene—Tripelennamine—Tamoxifen—breast cancer	0.00829	0.0363	CrCrCtD
Dextropropoxyphene—CYP3A4—Exemestane—breast cancer	0.00791	0.0439	CbGbCtD
Dextropropoxyphene—CYP2C9—Idarubicin—breast cancer	0.00781	0.0434	CbGbCtD
Dextropropoxyphene—Dimetacrine—Tamoxifen—breast cancer	0.00775	0.034	CrCrCtD
Dextropropoxyphene—CYP2C8—Raloxifene—breast cancer	0.00748	0.0415	CbGbCtD
Dextropropoxyphene—Methadone—Tamoxifen—breast cancer	0.00728	0.0319	CrCrCtD
Dextropropoxyphene—CYP2D6—Idarubicin—breast cancer	0.00715	0.0396	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.00685	0.038	CbGbCtD
Dextropropoxyphene—CYP3A7—Tamoxifen—breast cancer	0.00685	0.038	CbGbCtD
Dextropropoxyphene—CYP3A4—Letrozole—breast cancer	0.00673	0.0373	CbGbCtD
Dextropropoxyphene—Clofedanol—Tamoxifen—breast cancer	0.00629	0.0276	CrCrCtD
Dextropropoxyphene—Benzphetamine—Tamoxifen—breast cancer	0.00609	0.0267	CrCrCtD
Dextropropoxyphene—Orphenadrine—Tamoxifen—breast cancer	0.00609	0.0267	CrCrCtD
Dextropropoxyphene—CYP3A4—Anastrozole—breast cancer	0.006	0.0333	CbGbCtD
Dextropropoxyphene—Benzyl Benzoate—Tamoxifen—breast cancer	0.00564	0.0247	CrCrCtD
Dextropropoxyphene—CYP3A4—Toremifene—breast cancer	0.00548	0.0304	CbGbCtD
Dextropropoxyphene—Diphenhydramine—Tamoxifen—breast cancer	0.00541	0.0237	CrCrCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.00533	0.0296	CbGbCtD
Dextropropoxyphene—CYP3A7—Paclitaxel—breast cancer	0.00533	0.0296	CbGbCtD
Dextropropoxyphene—CYP3A7—Irinotecan—breast cancer	0.00526	0.0292	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00526	0.0292	CbGbCtD
Dextropropoxyphene—CYP3A4—Fulvestrant—breast cancer	0.0051	0.0283	CbGbCtD
Dextropropoxyphene—CYP2C8—Tamoxifen—breast cancer	0.00494	0.0274	CbGbCtD
Dextropropoxyphene—CYP3A4—Thiotepa—breast cancer	0.00454	0.0252	CbGbCtD
Dextropropoxyphene—CYP2C9—Capecitabine—breast cancer	0.00428	0.0238	CbGbCtD
Dextropropoxyphene—CYP3A4—Ixabepilone—breast cancer	0.00416	0.0231	CbGbCtD
Dextropropoxyphene—CYP3A4—Lapatinib—breast cancer	0.004	0.0222	CbGbCtD
Dextropropoxyphene—CYP3A7—Docetaxel—breast cancer	0.00385	0.0214	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00385	0.0214	CbGbCtD
Dextropropoxyphene—CYP2C8—Paclitaxel—breast cancer	0.00384	0.0213	CbGbCtD
Dextropropoxyphene—CYP2C8—Fluorouracil—breast cancer	0.00364	0.0202	CbGbCtD
Dextropropoxyphene—CYP2D6—Vinorelbine—breast cancer	0.00349	0.0194	CbGbCtD
Dextropropoxyphene—CYP2C9—Tamoxifen—breast cancer	0.00345	0.0191	CbGbCtD
Dextropropoxyphene—CYP2D6—Tamoxifen—breast cancer	0.00315	0.0175	CbGbCtD
Dextropropoxyphene—CYP3A4—Raloxifene—breast cancer	0.00303	0.0168	CbGbCtD
Dextropropoxyphene—CYP2C9—Paclitaxel—breast cancer	0.00268	0.0149	CbGbCtD
Dextropropoxyphene—CYP2C9—Fluorouracil—breast cancer	0.00254	0.0141	CbGbCtD
Dextropropoxyphene—CYP3A4—Vinorelbine—breast cancer	0.00222	0.0123	CbGbCtD
Dextropropoxyphene—CYP2D6—Vinblastine—breast cancer	0.00215	0.0119	CbGbCtD
Dextropropoxyphene—CYP3A4—Tamoxifen—breast cancer	0.002	0.0111	CbGbCtD
Dextropropoxyphene—CYP3A4—Mitoxantrone—breast cancer	0.00195	0.0108	CbGbCtD
Dextropropoxyphene—CYP3A4—Paclitaxel—breast cancer	0.00156	0.00865	CbGbCtD
Dextropropoxyphene—CYP3A4—Irinotecan—breast cancer	0.00154	0.00853	CbGbCtD
Dextropropoxyphene—CYP3A4—Vinblastine—breast cancer	0.00137	0.00759	CbGbCtD
Dextropropoxyphene—CYP2D6—Doxorubicin—breast cancer	0.00132	0.00733	CbGbCtD
Dextropropoxyphene—CYP3A4—Docetaxel—breast cancer	0.00113	0.00625	CbGbCtD
Dextropropoxyphene—CYP3A4—Doxorubicin—breast cancer	0.00084	0.00466	CbGbCtD
Dextropropoxyphene—Tamoxifen—ESRRA—breast cancer	0.000184	0.121	CrCbGaD
Dextropropoxyphene—Dimetacrine—ACHE—breast cancer	0.000148	0.0974	CrCbGaD
Dextropropoxyphene—Tamoxifen—SULT1A1—breast cancer	0.00014	0.0918	CrCbGaD
Dextropropoxyphene—Toremifene—ESR1—breast cancer	6.06e-05	0.0398	CrCbGaD
Dextropropoxyphene—Toremifene—CYP1A1—breast cancer	4.84e-05	0.0318	CrCbGaD
Dextropropoxyphene—Orphenadrine—SCN10A—breast cancer	4.55e-05	0.0299	CrCbGaD
Dextropropoxyphene—Levomethadyl Acetate—CYP19A1—breast cancer	4.45e-05	0.0292	CrCbGaD
Dextropropoxyphene—Phenylbutazone—PTGS1—breast cancer	3.99e-05	0.0262	CrCbGaD
Dextropropoxyphene—Tamoxifen—ESR2—breast cancer	3.93e-05	0.0258	CrCbGaD
Dextropropoxyphene—Tripelennamine—CYP2D6—breast cancer	3.75e-05	0.0246	CrCbGaD
Dextropropoxyphene—Discomfort—Paclitaxel—breast cancer	3.74e-05	0.000661	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Doxorubicin—breast cancer	3.71e-05	0.000656	CcSEcCtD
Dextropropoxyphene—Constipation—Gemcitabine—breast cancer	3.7e-05	0.000655	CcSEcCtD
Dextropropoxyphene—Asthenia—Thiotepa—breast cancer	3.69e-05	0.000653	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Vinorelbine—breast cancer	3.69e-05	0.000652	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Fluorouracil—breast cancer	3.68e-05	0.00065	CcSEcCtD
Dextropropoxyphene—Ataxia—Doxorubicin—breast cancer	3.67e-05	0.000649	CcSEcCtD
Dextropropoxyphene—Nausea—Melphalan—breast cancer	3.67e-05	0.000648	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Mitoxantrone—breast cancer	3.66e-05	0.000648	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Irinotecan—breast cancer	3.66e-05	0.000648	CcSEcCtD
Dextropropoxyphene—Confusional state—Paclitaxel—breast cancer	3.66e-05	0.000646	CcSEcCtD
Dextropropoxyphene—Malnutrition—Capecitabine—breast cancer	3.65e-05	0.000645	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Irinotecan—breast cancer	3.64e-05	0.000643	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Mitoxantrone—breast cancer	3.64e-05	0.000643	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Doxorubicin—breast cancer	3.6e-05	0.000637	CcSEcCtD
Dextropropoxyphene—Tamoxifen—CYP1B1—breast cancer	3.58e-05	0.0236	CrCbGaD
Dextropropoxyphene—Nausea—Goserelin—breast cancer	3.58e-05	0.000632	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Gemcitabine—breast cancer	3.57e-05	0.000631	CcSEcCtD
Dextropropoxyphene—Shock—Paclitaxel—breast cancer	3.57e-05	0.000631	CcSEcCtD
Dextropropoxyphene—Dizziness—Vinorelbine—breast cancer	3.57e-05	0.00063	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Paclitaxel—breast cancer	3.56e-05	0.000629	CcSEcCtD
Dextropropoxyphene—Tachycardia—Paclitaxel—breast cancer	3.54e-05	0.000626	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Thiotepa—breast cancer	3.52e-05	0.000623	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Mitoxantrone—breast cancer	3.52e-05	0.000621	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Irinotecan—breast cancer	3.52e-05	0.000621	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Fluorouracil—breast cancer	3.51e-05	0.00062	CcSEcCtD
Dextropropoxyphene—Drowsiness—Methotrexate—breast cancer	3.47e-05	0.000614	CcSEcCtD
Dextropropoxyphene—Vision blurred—Capecitabine—breast cancer	3.44e-05	0.000608	CcSEcCtD
Dextropropoxyphene—Vomiting—Vinorelbine—breast cancer	3.43e-05	0.000606	CcSEcCtD
Dextropropoxyphene—Dizziness—Thiotepa—breast cancer	3.4e-05	0.000602	CcSEcCtD
Dextropropoxyphene—Rash—Vinorelbine—breast cancer	3.4e-05	0.000601	CcSEcCtD
Dextropropoxyphene—Dermatitis—Vinorelbine—breast cancer	3.4e-05	0.0006	CcSEcCtD
Dextropropoxyphene—Hypotension—Paclitaxel—breast cancer	3.39e-05	0.000599	CcSEcCtD
Dextropropoxyphene—Headache—Vinorelbine—breast cancer	3.38e-05	0.000597	CcSEcCtD
Dextropropoxyphene—Syncope—Docetaxel—breast cancer	3.38e-05	0.000597	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Docetaxel—breast cancer	3.31e-05	0.000585	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Methotrexate—breast cancer	3.29e-05	0.000581	CcSEcCtD
Dextropropoxyphene—Insomnia—Paclitaxel—breast cancer	3.28e-05	0.00058	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Irinotecan—breast cancer	3.28e-05	0.000579	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Mitoxantrone—breast cancer	3.28e-05	0.000579	CcSEcCtD
Dextropropoxyphene—Vomiting—Thiotepa—breast cancer	3.27e-05	0.000579	CcSEcCtD
Dextropropoxyphene—Syncope—Capecitabine—breast cancer	3.27e-05	0.000578	CcSEcCtD
Dextropropoxyphene—Convulsion—Docetaxel—breast cancer	3.26e-05	0.000577	CcSEcCtD
Dextropropoxyphene—Drowsiness—Epirubicin—breast cancer	3.25e-05	0.000575	CcSEcCtD
Dextropropoxyphene—Rash—Thiotepa—breast cancer	3.25e-05	0.000574	CcSEcCtD
Dextropropoxyphene—Dermatitis—Thiotepa—breast cancer	3.24e-05	0.000573	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Paclitaxel—breast cancer	3.23e-05	0.000572	CcSEcCtD
Dextropropoxyphene—Headache—Thiotepa—breast cancer	3.23e-05	0.00057	CcSEcCtD
Dextropropoxyphene—Somnolence—Paclitaxel—breast cancer	3.22e-05	0.00057	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Capecitabine—breast cancer	3.2e-05	0.000567	CcSEcCtD
Dextropropoxyphene—Nausea—Vinorelbine—breast cancer	3.2e-05	0.000566	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Paclitaxel—breast cancer	3.19e-05	0.000564	CcSEcCtD
Dextropropoxyphene—Asthenia—Mitoxantrone—breast cancer	3.19e-05	0.000564	CcSEcCtD
Dextropropoxyphene—Asthenia—Irinotecan—breast cancer	3.19e-05	0.000564	CcSEcCtD
Dextropropoxyphene—Jaundice—Epirubicin—breast cancer	3.17e-05	0.00056	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Fluorouracil—breast cancer	3.14e-05	0.000555	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Paclitaxel—breast cancer	3.13e-05	0.000554	CcSEcCtD
Dextropropoxyphene—Asthenia—Gemcitabine—breast cancer	3.11e-05	0.000549	CcSEcCtD
Dextropropoxyphene—Constipation—Paclitaxel—breast cancer	3.1e-05	0.000548	CcSEcCtD
Dextropropoxyphene—Confusional state—Docetaxel—breast cancer	3.1e-05	0.000548	CcSEcCtD
Dextropropoxyphene—Toremifene—CYP3A4—breast cancer	3.09e-05	0.0203	CrCbGaD
Dextropropoxyphene—Hepatobiliary disease—Epirubicin—breast cancer	3.07e-05	0.000544	CcSEcCtD
Dextropropoxyphene—Discomfort—Capecitabine—breast cancer	3.07e-05	0.000542	CcSEcCtD
Dextropropoxyphene—Nausea—Thiotepa—breast cancer	3.06e-05	0.000541	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Mitoxantrone—breast cancer	3.04e-05	0.000538	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Irinotecan—breast cancer	3.04e-05	0.000538	CcSEcCtD
Dextropropoxyphene—Shock—Docetaxel—breast cancer	3.02e-05	0.000535	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Docetaxel—breast cancer	3.01e-05	0.000533	CcSEcCtD
Dextropropoxyphene—Drowsiness—Doxorubicin—breast cancer	3.01e-05	0.000532	CcSEcCtD
Dextropropoxyphene—Visual impairment—Methotrexate—breast cancer	3.01e-05	0.000531	CcSEcCtD
Dextropropoxyphene—Confusional state—Capecitabine—breast cancer	3e-05	0.000531	CcSEcCtD
Dextropropoxyphene—Tachycardia—Docetaxel—breast cancer	3e-05	0.00053	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Paclitaxel—breast cancer	2.99e-05	0.000528	CcSEcCtD
Dextropropoxyphene—Bradycardia—Epirubicin—breast cancer	2.97e-05	0.000525	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Paclitaxel—breast cancer	2.97e-05	0.000524	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Gemcitabine—breast cancer	2.96e-05	0.000524	CcSEcCtD
Dextropropoxyphene—Dizziness—Irinotecan—breast cancer	2.94e-05	0.00052	CcSEcCtD
Dextropropoxyphene—Jaundice—Doxorubicin—breast cancer	2.93e-05	0.000518	CcSEcCtD
Dextropropoxyphene—Shock—Capecitabine—breast cancer	2.93e-05	0.000518	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Capecitabine—breast cancer	2.92e-05	0.000516	CcSEcCtD
Dextropropoxyphene—Eye disorder—Methotrexate—breast cancer	2.91e-05	0.000515	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Fluorouracil—breast cancer	2.91e-05	0.000515	CcSEcCtD
Dextropropoxyphene—Tachycardia—Capecitabine—breast cancer	2.9e-05	0.000514	CcSEcCtD
Dextropropoxyphene—Alimemazine—CYP3A4—breast cancer	2.9e-05	0.0191	CrCbGaD
Dextropropoxyphene—Cardiac disorder—Methotrexate—breast cancer	2.89e-05	0.000512	CcSEcCtD
Dextropropoxyphene—Hypotension—Docetaxel—breast cancer	2.87e-05	0.000508	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Paclitaxel—breast cancer	2.87e-05	0.000507	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Doxorubicin—breast cancer	2.84e-05	0.000503	CcSEcCtD
Dextropropoxyphene—Vomiting—Mitoxantrone—breast cancer	2.83e-05	0.0005	CcSEcCtD
Dextropropoxyphene—Vomiting—Irinotecan—breast cancer	2.83e-05	0.0005	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Methotrexate—breast cancer	2.82e-05	0.000498	CcSEcCtD
Dextropropoxyphene—Dizziness—Fluorouracil—breast cancer	2.82e-05	0.000498	CcSEcCtD
Dextropropoxyphene—Visual impairment—Epirubicin—breast cancer	2.81e-05	0.000497	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Methotrexate—breast cancer	2.81e-05	0.000497	CcSEcCtD
Dextropropoxyphene—Rash—Irinotecan—breast cancer	2.8e-05	0.000496	CcSEcCtD
Dextropropoxyphene—Rash—Mitoxantrone—breast cancer	2.8e-05	0.000496	CcSEcCtD
Dextropropoxyphene—Dermatitis—Mitoxantrone—breast cancer	2.8e-05	0.000495	CcSEcCtD
Dextropropoxyphene—Dermatitis—Irinotecan—breast cancer	2.8e-05	0.000495	CcSEcCtD
Dextropropoxyphene—Headache—Irinotecan—breast cancer	2.79e-05	0.000492	CcSEcCtD
Dextropropoxyphene—Headache—Mitoxantrone—breast cancer	2.79e-05	0.000492	CcSEcCtD
Dextropropoxyphene—Hypotension—Capecitabine—breast cancer	2.78e-05	0.000492	CcSEcCtD
Dextropropoxyphene—Insomnia—Docetaxel—breast cancer	2.78e-05	0.000492	CcSEcCtD
Dextropropoxyphene—Vomiting—Gemcitabine—breast cancer	2.75e-05	0.000487	CcSEcCtD
Dextropropoxyphene—Bradycardia—Doxorubicin—breast cancer	2.75e-05	0.000486	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Docetaxel—breast cancer	2.74e-05	0.000485	CcSEcCtD
Dextropropoxyphene—Somnolence—Docetaxel—breast cancer	2.73e-05	0.000483	CcSEcCtD
Dextropropoxyphene—Rash—Gemcitabine—breast cancer	2.73e-05	0.000483	CcSEcCtD
Dextropropoxyphene—Dermatitis—Gemcitabine—breast cancer	2.73e-05	0.000482	CcSEcCtD
Dextropropoxyphene—Eye disorder—Epirubicin—breast cancer	2.73e-05	0.000482	CcSEcCtD
Dextropropoxyphene—Malnutrition—Methotrexate—breast cancer	2.71e-05	0.00048	CcSEcCtD
Dextropropoxyphene—Headache—Gemcitabine—breast cancer	2.71e-05	0.00048	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Epirubicin—breast cancer	2.71e-05	0.000479	CcSEcCtD
Dextropropoxyphene—Vomiting—Fluorouracil—breast cancer	2.71e-05	0.000479	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Docetaxel—breast cancer	2.71e-05	0.000478	CcSEcCtD
Dextropropoxyphene—Insomnia—Capecitabine—breast cancer	2.69e-05	0.000476	CcSEcCtD
Dextropropoxyphene—Rash—Fluorouracil—breast cancer	2.69e-05	0.000475	CcSEcCtD
Dextropropoxyphene—Dermatitis—Fluorouracil—breast cancer	2.68e-05	0.000474	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Paclitaxel—breast cancer	2.67e-05	0.000472	CcSEcCtD
Dextropropoxyphene—Headache—Fluorouracil—breast cancer	2.67e-05	0.000472	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Docetaxel—breast cancer	2.65e-05	0.000469	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Capecitabine—breast cancer	2.65e-05	0.000469	CcSEcCtD
Dextropropoxyphene—Nausea—Irinotecan—breast cancer	2.64e-05	0.000467	CcSEcCtD
Dextropropoxyphene—Nausea—Mitoxantrone—breast cancer	2.64e-05	0.000467	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Epirubicin—breast cancer	2.64e-05	0.000466	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Epirubicin—breast cancer	2.63e-05	0.000465	CcSEcCtD
Dextropropoxyphene—Tamoxifen—CYP19A1—breast cancer	2.63e-05	0.0173	CrCbGaD
Dextropropoxyphene—Constipation—Docetaxel—breast cancer	2.63e-05	0.000465	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Capecitabine—breast cancer	2.62e-05	0.000463	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Epirubicin—breast cancer	2.61e-05	0.000461	CcSEcCtD
Dextropropoxyphene—Methadone—CYP19A1—breast cancer	2.61e-05	0.0171	CrCbGaD
Dextropropoxyphene—Visual impairment—Doxorubicin—breast cancer	2.6e-05	0.00046	CcSEcCtD
Dextropropoxyphene—Asthenia—Paclitaxel—breast cancer	2.6e-05	0.00046	CcSEcCtD
Dextropropoxyphene—Toremifene—ABCB1—breast cancer	2.57e-05	0.0169	CrCbGaD
Dextropropoxyphene—Nausea—Gemcitabine—breast cancer	2.57e-05	0.000455	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Capecitabine—breast cancer	2.57e-05	0.000454	CcSEcCtD
Dextropropoxyphene—Disopyramide—CYP3A4—breast cancer	2.56e-05	0.0168	CrCbGaD
Dextropropoxyphene—Vision blurred—Methotrexate—breast cancer	2.56e-05	0.000452	CcSEcCtD
Dextropropoxyphene—Constipation—Capecitabine—breast cancer	2.54e-05	0.00045	CcSEcCtD
Dextropropoxyphene—Malnutrition—Epirubicin—breast cancer	2.54e-05	0.000449	CcSEcCtD
Dextropropoxyphene—Propafenone—CYP2D6—breast cancer	2.54e-05	0.0167	CrCbGaD
Dextropropoxyphene—Feeling abnormal—Docetaxel—breast cancer	2.53e-05	0.000448	CcSEcCtD
Dextropropoxyphene—Nausea—Fluorouracil—breast cancer	2.53e-05	0.000447	CcSEcCtD
Dextropropoxyphene—Eye disorder—Doxorubicin—breast cancer	2.52e-05	0.000446	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Docetaxel—breast cancer	2.51e-05	0.000444	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Doxorubicin—breast cancer	2.51e-05	0.000443	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Paclitaxel—breast cancer	2.48e-05	0.000439	CcSEcCtD
Dextropropoxyphene—Tamoxifen—ABCG2—breast cancer	2.47e-05	0.0162	CrCbGaD
Dextropropoxyphene—Feeling abnormal—Capecitabine—breast cancer	2.45e-05	0.000434	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Doxorubicin—breast cancer	2.44e-05	0.000431	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Capecitabine—breast cancer	2.43e-05	0.00043	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Doxorubicin—breast cancer	2.43e-05	0.00043	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Docetaxel—breast cancer	2.43e-05	0.00043	CcSEcCtD
Dextropropoxyphene—Tamoxifen—ESR1—breast cancer	2.42e-05	0.0159	CrCbGaD
Dextropropoxyphene—Arrhythmia—Doxorubicin—breast cancer	2.41e-05	0.000426	CcSEcCtD
Dextropropoxyphene—Dizziness—Paclitaxel—breast cancer	2.4e-05	0.000424	CcSEcCtD
Dextropropoxyphene—Vision blurred—Epirubicin—breast cancer	2.39e-05	0.000423	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Capecitabine—breast cancer	2.35e-05	0.000416	CcSEcCtD
Dextropropoxyphene—Convulsion—Methotrexate—breast cancer	2.35e-05	0.000416	CcSEcCtD
Dextropropoxyphene—Malnutrition—Doxorubicin—breast cancer	2.35e-05	0.000416	CcSEcCtD
Dextropropoxyphene—Agitation—Epirubicin—breast cancer	2.33e-05	0.000413	CcSEcCtD
Dextropropoxyphene—Phenylbutazone—CYP3A4—breast cancer	2.33e-05	0.0153	CrCbGaD
Dextropropoxyphene—Vomiting—Paclitaxel—breast cancer	2.31e-05	0.000408	CcSEcCtD
Dextropropoxyphene—Rash—Paclitaxel—breast cancer	2.29e-05	0.000404	CcSEcCtD
Dextropropoxyphene—Dermatitis—Paclitaxel—breast cancer	2.28e-05	0.000404	CcSEcCtD
Dextropropoxyphene—Discomfort—Methotrexate—breast cancer	2.28e-05	0.000404	CcSEcCtD
Dextropropoxyphene—Phenylbutazone—PTGS2—breast cancer	2.28e-05	0.015	CrCbGaD
Dextropropoxyphene—Syncope—Epirubicin—breast cancer	2.28e-05	0.000403	CcSEcCtD
Dextropropoxyphene—Headache—Paclitaxel—breast cancer	2.27e-05	0.000402	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Docetaxel—breast cancer	2.26e-05	0.0004	CcSEcCtD
Dextropropoxyphene—Bepridil—CYP2D6—breast cancer	2.26e-05	0.0149	CrCbGaD
Dextropropoxyphene—Confusional state—Methotrexate—breast cancer	2.23e-05	0.000395	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Epirubicin—breast cancer	2.23e-05	0.000395	CcSEcCtD
Dextropropoxyphene—Vision blurred—Doxorubicin—breast cancer	2.22e-05	0.000392	CcSEcCtD
Dextropropoxyphene—Asthenia—Docetaxel—breast cancer	2.21e-05	0.00039	CcSEcCtD
Dextropropoxyphene—Convulsion—Epirubicin—breast cancer	2.2e-05	0.000389	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Capecitabine—breast cancer	2.19e-05	0.000388	CcSEcCtD
Dextropropoxyphene—Propafenone—CYP3A4—breast cancer	2.18e-05	0.0143	CrCbGaD
Dextropropoxyphene—Nervous system disorder—Methotrexate—breast cancer	2.17e-05	0.000384	CcSEcCtD
Dextropropoxyphene—Diphenhydramine—PTGS1—breast cancer	2.17e-05	0.0143	CrCbGaD
Dextropropoxyphene—Agitation—Doxorubicin—breast cancer	2.16e-05	0.000382	CcSEcCtD
Dextropropoxyphene—Nausea—Paclitaxel—breast cancer	2.15e-05	0.000381	CcSEcCtD
Dextropropoxyphene—Discomfort—Epirubicin—breast cancer	2.14e-05	0.000378	CcSEcCtD
Dextropropoxyphene—Asthenia—Capecitabine—breast cancer	2.14e-05	0.000378	CcSEcCtD
Dextropropoxyphene—Syncope—Doxorubicin—breast cancer	2.11e-05	0.000373	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Docetaxel—breast cancer	2.1e-05	0.000372	CcSEcCtD
Dextropropoxyphene—Confusional state—Epirubicin—breast cancer	2.09e-05	0.00037	CcSEcCtD
Dextropropoxyphene—Levomethadyl Acetate—CYP3A4—breast cancer	2.09e-05	0.0137	CrCbGaD
Dextropropoxyphene—Hypotension—Methotrexate—breast cancer	2.07e-05	0.000366	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Doxorubicin—breast cancer	2.07e-05	0.000365	CcSEcCtD
Dextropropoxyphene—Shock—Epirubicin—breast cancer	2.04e-05	0.000361	CcSEcCtD
Dextropropoxyphene—Convulsion—Doxorubicin—breast cancer	2.04e-05	0.00036	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Capecitabine—breast cancer	2.04e-05	0.00036	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Epirubicin—breast cancer	2.03e-05	0.000359	CcSEcCtD
Dextropropoxyphene—Dizziness—Docetaxel—breast cancer	2.03e-05	0.000359	CcSEcCtD
Dextropropoxyphene—Tachycardia—Epirubicin—breast cancer	2.02e-05	0.000358	CcSEcCtD
Dextropropoxyphene—Loperamide—CYP2D6—breast cancer	2e-05	0.0132	CrCbGaD
Dextropropoxyphene—Insomnia—Methotrexate—breast cancer	2e-05	0.000354	CcSEcCtD
Dextropropoxyphene—Discomfort—Doxorubicin—breast cancer	1.98e-05	0.00035	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Methotrexate—breast cancer	1.98e-05	0.000349	CcSEcCtD
Dextropropoxyphene—Somnolence—Methotrexate—breast cancer	1.97e-05	0.000348	CcSEcCtD
Dextropropoxyphene—Dizziness—Capecitabine—breast cancer	1.97e-05	0.000348	CcSEcCtD
Dextropropoxyphene—Vomiting—Docetaxel—breast cancer	1.95e-05	0.000346	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Methotrexate—breast cancer	1.95e-05	0.000345	CcSEcCtD
Dextropropoxyphene—Rash—Docetaxel—breast cancer	1.94e-05	0.000343	CcSEcCtD
Dextropropoxyphene—Hypotension—Epirubicin—breast cancer	1.94e-05	0.000343	CcSEcCtD
Dextropropoxyphene—Dermatitis—Docetaxel—breast cancer	1.94e-05	0.000342	CcSEcCtD
Dextropropoxyphene—Confusional state—Doxorubicin—breast cancer	1.93e-05	0.000342	CcSEcCtD
Dextropropoxyphene—Tamoxifen—CYP1A1—breast cancer	1.93e-05	0.0127	CrCbGaD
Dextropropoxyphene—Headache—Docetaxel—breast cancer	1.93e-05	0.00034	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Methotrexate—breast cancer	1.91e-05	0.000338	CcSEcCtD
Dextropropoxyphene—Vomiting—Capecitabine—breast cancer	1.89e-05	0.000335	CcSEcCtD
Dextropropoxyphene—Shock—Doxorubicin—breast cancer	1.89e-05	0.000334	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Doxorubicin—breast cancer	1.88e-05	0.000333	CcSEcCtD
Dextropropoxyphene—Rash—Capecitabine—breast cancer	1.88e-05	0.000332	CcSEcCtD
Dextropropoxyphene—Insomnia—Epirubicin—breast cancer	1.88e-05	0.000332	CcSEcCtD
Dextropropoxyphene—Dermatitis—Capecitabine—breast cancer	1.87e-05	0.000331	CcSEcCtD
Dextropropoxyphene—Tachycardia—Doxorubicin—breast cancer	1.87e-05	0.000331	CcSEcCtD
Dextropropoxyphene—Headache—Capecitabine—breast cancer	1.86e-05	0.00033	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Epirubicin—breast cancer	1.85e-05	0.000327	CcSEcCtD
Dextropropoxyphene—Somnolence—Epirubicin—breast cancer	1.84e-05	0.000326	CcSEcCtD
Dextropropoxyphene—Nausea—Docetaxel—breast cancer	1.83e-05	0.000323	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Methotrexate—breast cancer	1.83e-05	0.000323	CcSEcCtD
Dextropropoxyphene—Modafinil—CYP3A4—breast cancer	1.83e-05	0.012	CrCbGaD
Dextropropoxyphene—Dyspepsia—Epirubicin—breast cancer	1.82e-05	0.000323	CcSEcCtD
Dextropropoxyphene—Propafenone—ABCB1—breast cancer	1.81e-05	0.0119	CrCbGaD
Dextropropoxyphene—Gastrointestinal pain—Methotrexate—breast cancer	1.81e-05	0.00032	CcSEcCtD
Dextropropoxyphene—Hypotension—Doxorubicin—breast cancer	1.79e-05	0.000317	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Epirubicin—breast cancer	1.79e-05	0.000316	CcSEcCtD
Dextropropoxyphene—Fentanyl—CYP3A4—breast cancer	1.79e-05	0.0117	CrCbGaD
Dextropropoxyphene—Constipation—Epirubicin—breast cancer	1.77e-05	0.000313	CcSEcCtD
Dextropropoxyphene—Nausea—Capecitabine—breast cancer	1.77e-05	0.000313	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Methotrexate—breast cancer	1.75e-05	0.00031	CcSEcCtD
Dextropropoxyphene—Insomnia—Doxorubicin—breast cancer	1.74e-05	0.000307	CcSEcCtD
Dextropropoxyphene—Loperamide—CYP3A4—breast cancer	1.72e-05	0.0113	CrCbGaD
Dextropropoxyphene—Dyspnoea—Doxorubicin—breast cancer	1.71e-05	0.000302	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Epirubicin—breast cancer	1.71e-05	0.000302	CcSEcCtD
Dextropropoxyphene—Somnolence—Doxorubicin—breast cancer	1.71e-05	0.000302	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Epirubicin—breast cancer	1.7e-05	0.0003	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Doxorubicin—breast cancer	1.69e-05	0.000299	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Doxorubicin—breast cancer	1.66e-05	0.000293	CcSEcCtD
Dextropropoxyphene—Constipation—Doxorubicin—breast cancer	1.64e-05	0.00029	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Epirubicin—breast cancer	1.64e-05	0.00029	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Methotrexate—breast cancer	1.63e-05	0.000289	CcSEcCtD
Dextropropoxyphene—Bepridil—ABCB1—breast cancer	1.62e-05	0.0106	CrCbGaD
Dextropropoxyphene—Asthenia—Methotrexate—breast cancer	1.59e-05	0.000281	CcSEcCtD
Dextropropoxyphene—Benzphetamine—CYP3A4—breast cancer	1.58e-05	0.0104	CrCbGaD
Dextropropoxyphene—Feeling abnormal—Doxorubicin—breast cancer	1.58e-05	0.000279	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Doxorubicin—breast cancer	1.57e-05	0.000277	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Epirubicin—breast cancer	1.53e-05	0.00027	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Doxorubicin—breast cancer	1.52e-05	0.000268	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Methotrexate—breast cancer	1.52e-05	0.000268	CcSEcCtD
Dextropropoxyphene—Phenoxybenzamine—CYP3A4—breast cancer	1.51e-05	0.00994	CrCbGaD
Dextropropoxyphene—Trimipramine—CYP2D6—breast cancer	1.51e-05	0.0099	CrCbGaD
Dextropropoxyphene—Asthenia—Epirubicin—breast cancer	1.49e-05	0.000263	CcSEcCtD
Dextropropoxyphene—Fentanyl—ABCB1—breast cancer	1.49e-05	0.00977	CrCbGaD
Dextropropoxyphene—Diphenhydramine—CYP2D6—breast cancer	1.48e-05	0.00972	CrCbGaD
Dextropropoxyphene—Dizziness—Methotrexate—breast cancer	1.47e-05	0.000259	CcSEcCtD
Dextropropoxyphene—Tamoxifen—CYP2D6—breast cancer	1.44e-05	0.00946	CrCbGaD
Dextropropoxyphene—Loperamide—ABCB1—breast cancer	1.43e-05	0.00941	CrCbGaD
Dextropropoxyphene—Methadone—CYP2D6—breast cancer	1.43e-05	0.00938	CrCbGaD
Dextropropoxyphene—Diarrhoea—Epirubicin—breast cancer	1.42e-05	0.000251	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Doxorubicin—breast cancer	1.41e-05	0.00025	CcSEcCtD
Dextropropoxyphene—Vomiting—Methotrexate—breast cancer	1.41e-05	0.000249	CcSEcCtD
Dextropropoxyphene—Rash—Methotrexate—breast cancer	1.4e-05	0.000247	CcSEcCtD
Dextropropoxyphene—Dermatitis—Methotrexate—breast cancer	1.4e-05	0.000247	CcSEcCtD
Dextropropoxyphene—Headache—Methotrexate—breast cancer	1.39e-05	0.000245	CcSEcCtD
Dextropropoxyphene—Asthenia—Doxorubicin—breast cancer	1.38e-05	0.000243	CcSEcCtD
Dextropropoxyphene—Dizziness—Epirubicin—breast cancer	1.37e-05	0.000242	CcSEcCtD
Dextropropoxyphene—Vomiting—Epirubicin—breast cancer	1.32e-05	0.000233	CcSEcCtD
Dextropropoxyphene—Nausea—Methotrexate—breast cancer	1.32e-05	0.000233	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Doxorubicin—breast cancer	1.31e-05	0.000232	CcSEcCtD
Dextropropoxyphene—Rash—Epirubicin—breast cancer	1.31e-05	0.000231	CcSEcCtD
Dextropropoxyphene—Dermatitis—Epirubicin—breast cancer	1.31e-05	0.000231	CcSEcCtD
Dextropropoxyphene—Headache—Epirubicin—breast cancer	1.3e-05	0.00023	CcSEcCtD
Dextropropoxyphene—Trimipramine—CYP3A4—breast cancer	1.29e-05	0.00849	CrCbGaD
Dextropropoxyphene—Dizziness—Doxorubicin—breast cancer	1.27e-05	0.000224	CcSEcCtD
Dextropropoxyphene—Tamoxifen—CYP3A4—breast cancer	1.23e-05	0.00812	CrCbGaD
Dextropropoxyphene—Nausea—Epirubicin—breast cancer	1.23e-05	0.000218	CcSEcCtD
Dextropropoxyphene—Methadone—CYP3A4—breast cancer	1.22e-05	0.00805	CrCbGaD
Dextropropoxyphene—Vomiting—Doxorubicin—breast cancer	1.22e-05	0.000216	CcSEcCtD
Dextropropoxyphene—Rash—Doxorubicin—breast cancer	1.21e-05	0.000214	CcSEcCtD
Dextropropoxyphene—Dermatitis—Doxorubicin—breast cancer	1.21e-05	0.000214	CcSEcCtD
Dextropropoxyphene—Headache—Doxorubicin—breast cancer	1.2e-05	0.000212	CcSEcCtD
Dextropropoxyphene—Orphenadrine—CYP3A4—breast cancer	1.2e-05	0.00789	CrCbGaD
Dextropropoxyphene—Nausea—Doxorubicin—breast cancer	1.14e-05	0.000201	CcSEcCtD
Dextropropoxyphene—Trimipramine—ABCB1—breast cancer	1.08e-05	0.00707	CrCbGaD
Dextropropoxyphene—Tamoxifen—ABCB1—breast cancer	1.03e-05	0.00676	CrCbGaD
Dextropropoxyphene—Methadone—ABCB1—breast cancer	1.02e-05	0.0067	CrCbGaD
Dextropropoxyphene—CYP2C8—Metabolism—COMT—breast cancer	1.71e-06	6.9e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—IL6—breast cancer	1.7e-06	6.87e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTP1—breast cancer	1.7e-06	6.87e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NAT2—breast cancer	1.7e-06	6.86e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—BRAF—breast cancer	1.69e-06	6.84e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—PIK3CA—breast cancer	1.69e-06	6.81e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MDM2—breast cancer	1.68e-06	6.78e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—HMOX1—breast cancer	1.68e-06	6.77e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NQO1—breast cancer	1.67e-06	6.76e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SLC2A1—breast cancer	1.67e-06	6.76e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ITPR1—breast cancer	1.67e-06	6.76e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—RAF1—breast cancer	1.67e-06	6.76e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCND1—breast cancer	1.67e-06	6.73e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—RELA—breast cancer	1.67e-06	6.73e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—JUN—breast cancer	1.66e-06	6.72e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NQO1—breast cancer	1.66e-06	6.7e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SLC2A1—breast cancer	1.66e-06	6.7e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—ERBB2—breast cancer	1.66e-06	6.68e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CTNNB1—breast cancer	1.65e-06	6.67e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IGF1—breast cancer	1.65e-06	6.66e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—AKT2—breast cancer	1.65e-06	6.66e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—EGFR—breast cancer	1.64e-06	6.63e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MTOR—breast cancer	1.63e-06	6.6e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PIK3CB—breast cancer	1.63e-06	6.6e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP3A4—breast cancer	1.63e-06	6.59e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3CD—breast cancer	1.63e-06	6.58e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.63e-06	6.56e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MMP9—breast cancer	1.62e-06	6.54e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP3A4—breast cancer	1.62e-06	6.53e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CDKN1A—breast cancer	1.61e-06	6.51e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.61e-06	6.5e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PTEN—breast cancer	1.61e-06	6.5e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ABCB1—breast cancer	1.61e-06	6.5e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ALB—breast cancer	1.61e-06	6.49e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP1B1—breast cancer	1.6e-06	6.48e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP1B1—breast cancer	1.59e-06	6.42e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3CD—breast cancer	1.58e-06	6.4e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—TYMS—breast cancer	1.58e-06	6.38e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MAPK8—breast cancer	1.58e-06	6.36e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—HSP90AA1—breast cancer	1.57e-06	6.35e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—AKT1—breast cancer	1.57e-06	6.34e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CXCL8—breast cancer	1.57e-06	6.34e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—PIK3CA—breast cancer	1.57e-06	6.33e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SERPINE1—breast cancer	1.57e-06	6.33e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—NCOR1—breast cancer	1.56e-06	6.31e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PLA2G4A—breast cancer	1.56e-06	6.31e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTM1—breast cancer	1.56e-06	6.31e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—HSP90AA1—breast cancer	1.56e-06	6.3e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—HRAS—breast cancer	1.56e-06	6.3e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—KRAS—breast cancer	1.55e-06	6.26e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—NOS3—breast cancer	1.54e-06	6.21e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CDKN1B—breast cancer	1.53e-06	6.19e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NCOA1—breast cancer	1.53e-06	6.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NCOA1—breast cancer	1.52e-06	6.13e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—AKT1—breast cancer	1.52e-06	6.12e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—STK11—breast cancer	1.51e-06	6.09e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP19A1—breast cancer	1.51e-06	6.09e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CASP3—breast cancer	1.5e-06	6.07e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL2—breast cancer	1.5e-06	6.06e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GPX1—breast cancer	1.5e-06	6.04e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—STK11—breast cancer	1.5e-06	6.04e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP19A1—breast cancer	1.5e-06	6.04e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NOS3—breast cancer	1.5e-06	6.04e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—SRC—breast cancer	1.49e-06	6.03e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—IL6—breast cancer	1.49e-06	6.03e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—MED12—breast cancer	1.49e-06	6.01e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—DPYD—breast cancer	1.49e-06	6.01e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CYP1A1—breast cancer	1.48e-06	5.98e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ERCC2—breast cancer	1.47e-06	5.93e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALDOA—breast cancer	1.47e-06	5.92e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCND1—breast cancer	1.46e-06	5.91e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—JUN—breast cancer	1.46e-06	5.89e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—VEGFA—breast cancer	1.45e-06	5.87e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CTNNB1—breast cancer	1.45e-06	5.85e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—STAT3—breast cancer	1.44e-06	5.81e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—PIK3CA—breast cancer	1.42e-06	5.75e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NCOA3—breast cancer	1.42e-06	5.75e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3CB—breast cancer	1.42e-06	5.73e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MMP9—breast cancer	1.42e-06	5.73e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MDM2—breast cancer	1.42e-06	5.73e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CDKN1A—breast cancer	1.42e-06	5.71e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—RAF1—breast cancer	1.41e-06	5.71e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLC2A2—breast cancer	1.41e-06	5.71e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PTEN—breast cancer	1.41e-06	5.7e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—RELA—breast cancer	1.41e-06	5.68e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PTGS2—breast cancer	1.41e-06	5.68e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.4e-06	5.67e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—COMT—breast cancer	1.4e-06	5.66e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ERBB2—breast cancer	1.4e-06	5.65e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTP1—breast cancer	1.4e-06	5.64e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—COMT—breast cancer	1.39e-06	5.61e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ABCG2—breast cancer	1.38e-06	5.59e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CPT1A—breast cancer	1.38e-06	5.59e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—MTR—breast cancer	1.38e-06	5.59e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTP1—breast cancer	1.38e-06	5.59e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—MTHFR—breast cancer	1.38e-06	5.58e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MAPK8—breast cancer	1.38e-06	5.58e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MTOR—breast cancer	1.38e-06	5.57e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3CB—breast cancer	1.38e-06	5.57e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—AKT1—breast cancer	1.38e-06	5.56e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—HMOX1—breast cancer	1.38e-06	5.56e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MAPK3—breast cancer	1.38e-06	5.55e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ITPR1—breast cancer	1.37e-06	5.55e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—HMOX1—breast cancer	1.37e-06	5.51e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ITPR1—breast cancer	1.36e-06	5.5e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HPGDS—breast cancer	1.36e-06	5.48e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HBA1—breast cancer	1.35e-06	5.45e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MYC—breast cancer	1.34e-06	5.4e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TGFB1—breast cancer	1.33e-06	5.39e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CXCL8—breast cancer	1.33e-06	5.36e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ABCB1—breast cancer	1.32e-06	5.34e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—HRAS—breast cancer	1.32e-06	5.32e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ACHE—breast cancer	1.32e-06	5.32e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTT1—breast cancer	1.32e-06	5.32e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ABCB1—breast cancer	1.31e-06	5.29e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SRC—breast cancer	1.31e-06	5.29e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—EGFR—breast cancer	1.31e-06	5.28e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—TYMS—breast cancer	1.3e-06	5.24e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CDKN1B—breast cancer	1.3e-06	5.23e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—TYMS—breast cancer	1.29e-06	5.19e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTM1—breast cancer	1.28e-06	5.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NCOR1—breast cancer	1.28e-06	5.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.28e-06	5.18e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—AKT1—breast cancer	1.28e-06	5.17e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—VEGFA—breast cancer	1.28e-06	5.15e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CAV1—breast cancer	1.27e-06	5.14e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.27e-06	5.14e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTM1—breast cancer	1.27e-06	5.14e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NCOR1—breast cancer	1.27e-06	5.14e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CASP3—breast cancer	1.27e-06	5.13e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL2—breast cancer	1.27e-06	5.12e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—STAT3—breast cancer	1.26e-06	5.1e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—IL6—breast cancer	1.26e-06	5.09e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP17A1—breast cancer	1.25e-06	5.03e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—KRAS—breast cancer	1.24e-06	4.99e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCND1—breast cancer	1.24e-06	4.99e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ENO1—breast cancer	1.23e-06	4.98e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTGS1—breast cancer	1.23e-06	4.98e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—JUN—breast cancer	1.23e-06	4.98e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GPX1—breast cancer	1.23e-06	4.96e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PTEN—breast cancer	1.23e-06	4.95e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CTNNB1—breast cancer	1.22e-06	4.94e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GPX1—breast cancer	1.22e-06	4.92e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.22e-06	4.91e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP1A1—breast cancer	1.22e-06	4.91e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP2D6—breast cancer	1.21e-06	4.89e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ERCC2—breast cancer	1.21e-06	4.87e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MAPK3—breast cancer	1.21e-06	4.87e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP1A1—breast cancer	1.21e-06	4.87e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MMP9—breast cancer	1.2e-06	4.85e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ERCC2—breast cancer	1.2e-06	4.83e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CDKN1A—breast cancer	1.2e-06	4.83e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PTEN—breast cancer	1.19e-06	4.82e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NCOA2—breast cancer	1.19e-06	4.8e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MYC—breast cancer	1.17e-06	4.74e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TGFB1—breast cancer	1.17e-06	4.72e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MAPK8—breast cancer	1.17e-06	4.71e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—AKT1—breast cancer	1.16e-06	4.7e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CG—breast cancer	1.16e-06	4.68e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—FASN—breast cancer	1.15e-06	4.65e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—EGFR—breast cancer	1.15e-06	4.63e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—BCHE—breast cancer	1.15e-06	4.63e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PIK3CA—breast cancer	1.14e-06	4.59e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—MTHFR—breast cancer	1.13e-06	4.58e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLC5A5—breast cancer	1.13e-06	4.58e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—MTHFR—breast cancer	1.12e-06	4.54e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SRC—breast cancer	1.11e-06	4.47e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TP53—breast cancer	1.1e-06	4.44e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLC2A1—breast cancer	1.09e-06	4.42e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NQO1—breast cancer	1.09e-06	4.42e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—KRAS—breast cancer	1.08e-06	4.38e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—VEGFA—breast cancer	1.08e-06	4.35e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—STAT3—breast cancer	1.07e-06	4.31e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—HRAS—breast cancer	1.05e-06	4.24e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP1B1—breast cancer	1.05e-06	4.24e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CAV1—breast cancer	1.05e-06	4.22e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CAV1—breast cancer	1.04e-06	4.19e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.03e-06	4.15e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CD—breast cancer	1.02e-06	4.12e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MAPK3—breast cancer	1.02e-06	4.12e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ALB—breast cancer	1.01e-06	4.07e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL6—breast cancer	1.01e-06	4.06e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NCOA1—breast cancer	1e-06	4.04e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PIK3CA—breast cancer	9.96e-07	4.02e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MYC—breast cancer	9.92e-07	4e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.91e-07	4e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TGFB1—breast cancer	9.89e-07	3.99e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—STK11—breast cancer	9.87e-07	3.98e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP19A1—breast cancer	9.87e-07	3.98e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—EGFR—breast cancer	9.7e-07	3.92e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TP53—breast cancer	9.64e-07	3.89e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—NOS3—breast cancer	9.63e-07	3.89e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CG—breast cancer	9.53e-07	3.85e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CG—breast cancer	9.45e-07	3.81e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—AKT1—breast cancer	9.28e-07	3.75e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—HRAS—breast cancer	9.21e-07	3.72e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—COMT—breast cancer	9.17e-07	3.7e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—KRAS—breast cancer	9.16e-07	3.7e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTP1—breast cancer	9.13e-07	3.69e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HMOX1—breast cancer	9e-07	3.63e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ITPR1—breast cancer	8.98e-07	3.63e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CB—breast cancer	8.89e-07	3.59e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL6—breast cancer	8.82e-07	3.56e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PTGS2—breast cancer	8.81e-07	3.56e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3CA—breast cancer	8.66e-07	3.5e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ABCB1—breast cancer	8.64e-07	3.49e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—TYMS—breast cancer	8.49e-07	3.43e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3CA—breast cancer	8.42e-07	3.4e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NCOR1—breast cancer	8.39e-07	3.39e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTM1—breast cancer	8.39e-07	3.39e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PLA2G4A—breast cancer	8.39e-07	3.39e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CD—breast cancer	8.38e-07	3.38e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CD—breast cancer	8.3e-07	3.35e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ALB—breast cancer	8.27e-07	3.34e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ALB—breast cancer	8.2e-07	3.31e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TP53—breast cancer	8.14e-07	3.29e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—AKT1—breast cancer	8.14e-07	3.28e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GPX1—breast cancer	8.03e-07	3.24e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP1A1—breast cancer	7.95e-07	3.21e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NOS3—breast cancer	7.91e-07	3.19e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ERCC2—breast cancer	7.89e-07	3.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NOS3—breast cancer	7.84e-07	3.17e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HRAS—breast cancer	7.79e-07	3.14e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PTEN—breast cancer	7.68e-07	3.1e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL6—breast cancer	7.45e-07	3.01e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—MTHFR—breast cancer	7.41e-07	2.99e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CB—breast cancer	7.3e-07	2.95e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CB—breast cancer	7.24e-07	2.92e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PTGS2—breast cancer	7.23e-07	2.92e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PTGS2—breast cancer	7.17e-07	2.89e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—AKT1—breast cancer	7.07e-07	2.86e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—AKT1—breast cancer	6.88e-07	2.78e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CAV1—breast cancer	6.84e-07	2.76e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PTEN—breast cancer	6.31e-07	2.55e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PTEN—breast cancer	6.25e-07	2.52e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CG—breast cancer	6.23e-07	2.51e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CD—breast cancer	5.48e-07	2.21e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CA—breast cancer	5.42e-07	2.19e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALB—breast cancer	5.41e-07	2.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NOS3—breast cancer	5.17e-07	2.09e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CB—breast cancer	4.77e-07	1.93e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTGS2—breast cancer	4.73e-07	1.91e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CA—breast cancer	4.45e-07	1.8e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—AKT1—breast cancer	4.43e-07	1.79e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CA—breast cancer	4.41e-07	1.78e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTEN—breast cancer	4.12e-07	1.67e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—AKT1—breast cancer	3.64e-07	1.47e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—AKT1—breast cancer	3.6e-07	1.45e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CA—breast cancer	2.91e-07	1.17e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—AKT1—breast cancer	2.38e-07	9.6e-06	CbGpPWpGaD
